Across TCGA pan-cancer cohorts, MIR1301 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MIR1301 data layer.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MIR1301 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR1301 expression acts as an unfavorable survival marker, although some lineages such as LAML and BRCA show a favorable association.
BLCA, UCEC, and KIRC are the cancer types where MIR1301 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.